Bank of New York Mellon Corp decreased its position in shares of Dentsply International Inc. (NASDAQ:XRAY) by 3.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 4,176,942 shares of the company’s stock after selling 145,961 shares during the period. Bank of New York Mellon Corp’s holdings in Dentsply International were worth $248,236,000 as of its most recent filing with the SEC.

Several other institutional investors also recently added to or reduced their stakes in the stock. Sumitomo Mitsui Trust Holdings Inc. boosted its stake in Dentsply International by 12.7% in the second quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 786,336 shares of the company’s stock worth $48,784,000 after buying an additional 88,725 shares during the period. Bank of Montreal Can acquired a new stake in Dentsply International during the second quarter worth approximately $15,419,000. Harvey Investment Co. LLC boosted its stake in Dentsply International by 0.3% in the second quarter. Harvey Investment Co. LLC now owns 190,561 shares of the company’s stock worth $11,822,000 after buying an additional 499 shares during the period. Candriam Luxembourg S.C.A. boosted its stake in Dentsply International by 52.5% in the second quarter. Candriam Luxembourg S.C.A. now owns 212,680 shares of the company’s stock worth $13,195,000 after buying an additional 73,230 shares during the period. Finally, Channing Capital Management LLC boosted its stake in Dentsply International by 44.4% in the second quarter. Channing Capital Management LLC now owns 188,760 shares of the company’s stock worth $11,711,000 after buying an additional 57,999 shares during the period. Institutional investors and hedge funds own 93.48% of the company’s stock.

Institutional Ownership by Quarter for Dentsply International (NASDAQ:XRAY)

Dentsply International Inc. (NASDAQ:XRAY) opened at 58.18 on Thursday. The stock’s 50 day moving average price is $59.20 and its 200 day moving average price is $61.02. Dentsply International Inc. has a one year low of $53.43 and a one year high of $65.83.

Dentsply International (NASDAQ:XRAY) last announced its earnings results on Friday, November 4th. The company reported $0.66 EPS for the quarter, beating analysts’ consensus estimates of $0.63 by $0.03. Dentsply International had a net margin of 11.15% and a return on equity of 8.04%. The business earned $954.20 million during the quarter, compared to analysts’ expectations of $967.68 million. During the same period in the prior year, the company earned $0.66 earnings per share. The business’s revenue was up 47.0% compared to the same quarter last year. Equities research analysts forecast that Dentsply International Inc. will post $2.77 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: “Bank of New York Mellon Corp Sells 145,961 Shares of Dentsply International Inc. (XRAY)” was originally published by Daily Political and is the propert of of Daily Political. If you are viewing this news story on another publication, it was illegally copied and republished in violation of U.S. and international copyright law. The correct version of this news story can be read at http://www.dailypolitical.com/2016/12/01/bank-of-new-york-mellon-corp-sells-145961-shares-of-dentsply-international-inc-xray.html.

XRAY has been the topic of a number of analyst reports. Barrington Research cut Dentsply International from an “outperform” rating to a “market perform” rating in a research report on Monday, August 8th. Zacks Investment Research cut Dentsply International from a “buy” rating to a “hold” rating in a report on Monday, August 8th. Jefferies Group reiterated a “buy” rating on shares of Dentsply International in a report on Wednesday, August 17th. Bank of America Corp. initiated coverage on Dentsply International in a report on Monday, September 12th. They issued a “buy” rating and a $70.00 price objective on the stock. Finally, JPMorgan Chase & Co. initiated coverage on Dentsply International in a report on Thursday, September 22nd. They issued a “neutral” rating and a $65.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and six have issued a buy rating to the company. The company currently has an average rating of “Hold” and an average target price of $67.33.

In related news, VP Rainer Berthan sold 5,000 shares of the stock in a transaction dated Tuesday, September 6th. The shares were sold at an average price of $61.12, for a total transaction of $305,600.00. Following the completion of the transaction, the vice president now directly owns 34,370 shares of the company’s stock, valued at $2,100,694.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO James G. Mosch sold 30,400 shares of the stock in a transaction dated Thursday, November 17th. The stock was sold at an average price of $60.93, for a total transaction of $1,852,272.00. Following the transaction, the chief executive officer now directly owns 75,283 shares of the company’s stock, valued at $4,586,993.19. The disclosure for this sale can be found here. Corporate insiders own 2.20% of the company’s stock.

Dentsply International Company Profile

DENTSPLY SIRONA Inc, formerly DENTSPLY International Inc, designs, develops, manufactures and markets a range of consumable dental products for the professional dental market. The Company also manufactures and markets consumable medical device products consisting mainly of urological catheters and certain surgical products.

5 Day Chart for NASDAQ:XRAY

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dentsply International Inc. (NASDAQ:XRAY).

Receive News & Ratings for Dentsply International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dentsply International Inc. and related companies with MarketBeat.com's FREE daily email newsletter.